Literature DB >> 19093199

Time from positive screening fecal occult blood test to colonoscopy and risk of neoplasia.

Ziad F Gellad1, Daniel Almirall, Dawn Provenzale, Deborah A Fisher.   

Abstract

There is no guideline defining the optimal time from a positive screening fecal occult blood test to follow-up colonoscopy. We reviewed records of 231 consecutive primary care patients who received a colonoscopy within 18 months of a positive fecal occult blood test. We examined the relationship between time to colonoscopy and risk of neoplasia on colonoscopy using a logistic regression analysis adjusting for potential confounders such as age, race, and gender. The mean time to colonoscopy was 236 days. Longer time to colonoscopy (OR = 1.10, P = 0.01) and older age (OR 1.04, P = 0.01) were associated with higher odds of neoplasia. The association of time with advanced neoplasia was positive, but not statistically significant (OR 1.07, P = 0.14). In this study, a longer interval to colonoscopy after fecal occult blood test was associated with an increased risk of neoplasia. Determining the optimal interval for follow-up is desirable and will require larger studies.

Entities:  

Mesh:

Year:  2008        PMID: 19093199      PMCID: PMC3726721          DOI: 10.1007/s10620-008-0653-8

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  19 in total

1.  A paradox explained? Patients with delayed diagnosis of symptomatic colorectal cancer have good prognosis.

Authors:  K S Rupassara; S Ponnusamy; N Withanage; P J Milewski
Journal:  Colorectal Dis       Date:  2006-06       Impact factor: 3.788

2.  Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380.

Authors:  D A Lieberman; D G Weiss; J H Bond; D J Ahnen; H Garewal; G Chejfec
Journal:  N Engl J Med       Date:  2000-07-20       Impact factor: 91.245

3.  Barriers to full colon evaluation for a positive fecal occult blood test.

Authors:  Deborah A Fisher; Amy Jeffreys; Cynthia J Coffman; Kenneth Fasanella
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-06       Impact factor: 4.254

4.  Does high body fatness increase the risk of presence and growth of colorectal adenomas followed up in situ for 3 years?

Authors:  K Almendingen; B Hofstad; M H Vatn
Journal:  Am J Gastroenterol       Date:  2001-07       Impact factor: 10.864

5.  One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon.

Authors:  D A Lieberman; D G Weiss
Journal:  N Engl J Med       Date:  2001-08-23       Impact factor: 91.245

6.  Randomised controlled trial of faecal-occult-blood screening for colorectal cancer.

Authors:  J D Hardcastle; J O Chamberlain; M H Robinson; S M Moss; S S Amar; T W Balfour; P D James; C M Mangham
Journal:  Lancet       Date:  1996-11-30       Impact factor: 79.321

7.  A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, hemoccult.

Authors:  B Towler; L Irwig; P Glasziou; J Kewenter; D Weller; C Silagy
Journal:  BMJ       Date:  1998-08-29

Review 8.  Molecular heterogeneity of colorectal cancer: Implications for cancer control.

Authors:  Jeremy R Jass
Journal:  Surg Oncol       Date:  2007-11-26       Impact factor: 3.279

Review 9.  Obesity and risk of colorectal cancer: a meta-analysis of 31 studies with 70,000 events.

Authors:  Alireza Ansary Moghaddam; Mark Woodward; Rachel Huxley
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-12       Impact factor: 4.254

Review 10.  Emerging concepts in colorectal neoplasia.

Authors:  Jeremy R Jass; Vicki L J Whitehall; Joanne Young; Barbara A Leggett
Journal:  Gastroenterology       Date:  2002-09       Impact factor: 22.682

View more
  21 in total

1.  The Need for an Integrated Patient Navigation Pathway to Improve Access to Colonoscopy After Positive Fecal Immunochemical Testing: A Safety-Net Hospital Experience.

Authors:  Sreedevi Thamarasseril; Taft Bhuket; Chuck Chan; Benny Liu; Robert J Wong
Journal:  J Community Health       Date:  2017-06

Review 2.  Bringing an organizational perspective to the optimal number of colorectal cancer screening options debate.

Authors:  Melissa R Partin; Adam A Powell; Diana J Burgess; Timothy J Wilt
Journal:  J Gen Intern Med       Date:  2011-09-14       Impact factor: 5.128

3.  Determinants of medical system delay in the diagnosis of colorectal cancer within the Veteran Affairs Health System.

Authors:  Deborah A Fisher; Leah L Zullig; Steven C Grambow; David H Abbott; Robert S Sandler; Robert H Fletcher; Hashem B El-Serag; Dawn Provenzale
Journal:  Dig Dis Sci       Date:  2010-03-18       Impact factor: 3.199

4.  Patient Navigation After Positive Fecal Immunochemical Test Results Increases Diagnostic Colonoscopy and Highlights Multilevel Barriers to Follow-Up.

Authors:  Vivy T Cusumano; Anthony Myint; Edgar Corona; Liu Yang; Jennifer Bocek; Antonio G Lopez; Marcela Zhou Huang; Naveen Raja; Anna Dermenchyan; Lily Roh; Maria Han; Daniel Croymans; Folasade P May
Journal:  Dig Dis Sci       Date:  2021-02-20       Impact factor: 3.199

5.  Organizational predictors of colonoscopy follow-up for positive fecal occult blood test results: an observational study.

Authors:  Melissa R Partin; Diana J Burgess; James F Burgess; Amy Gravely; David Haggstrom; Sarah E Lillie; Sean Nugent; Adam A Powell; Aasma Shaukat; Louise C Walter; David B Nelson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-12-03       Impact factor: 4.254

6.  Time to Colonoscopy after Positive Fecal Blood Test in Four U.S. Health Care Systems.

Authors:  Jessica Chubak; Michael P Garcia; Andrea N Burnett-Hartman; Yingye Zheng; Douglas A Corley; Ethan A Halm; Amit G Singal; Carrie N Klabunde; Chyke A Doubeni; Aruna Kamineni; Theodore R Levin; Joanne E Schottinger; Beverly B Green; Virginia P Quinn; Carolyn M Rutter
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-02       Impact factor: 4.254

7.  Consequences of Increasing Time to Colonoscopy Examination After Positive Result From Fecal Colorectal Cancer Screening Test.

Authors:  Reinier G S Meester; Ann G Zauber; Chyke A Doubeni; Christopher D Jensen; Virginia P Quinn; Mark Helfand; Jason A Dominitz; Theodore R Levin; Douglas A Corley; Iris Lansdorp-Vogelaar
Journal:  Clin Gastroenterol Hepatol       Date:  2016-05-19       Impact factor: 11.382

8.  Time to Follow-up After Colorectal Cancer Screening by Health Insurance Type.

Authors:  Nancy Breen; Celette Sugg Skinner; Yingye Zheng; Stephen Inrig; Douglas A Corley; Elisabeth F Beaber; Mike Garcia; Jessica Chubak; Chyke Doubeni; Virginia P Quinn; Jennifer S Haas; Christopher I Li; Karen J Wernli; Carrie N Klabunde
Journal:  Am J Prev Med       Date:  2019-05       Impact factor: 5.043

9.  The diagnosis of colorectal cancer in patients with symptoms: finding a needle in a haystack.

Authors:  Robert H Fletcher
Journal:  BMC Med       Date:  2009-04-17       Impact factor: 8.775

10.  Timely follow-up of positive cancer screening results: A systematic review and recommendations from the PROSPR Consortium.

Authors:  Chyke A Doubeni; Nicole B Gabler; Cosette M Wheeler; Anne Marie McCarthy; Philip E Castle; Ethan A Halm; Mitchell D Schnall; Celette S Skinner; Anna N A Tosteson; Donald L Weaver; Anil Vachani; Shivan J Mehta; Katharine A Rendle; Stacey A Fedewa; Douglas A Corley; Katrina Armstrong
Journal:  CA Cancer J Clin       Date:  2018-03-30       Impact factor: 508.702

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.